Chimeric antigen receptor T, or CAR-T, cell therapy is a new therapy developed for a wide range of cancers. The main idea is to harvest T-cells from the patient and genetically engineer the cells in ...
Chimeric antigen receptor T cell therapy (CAR-T cell therapy) is a new kind of immunotherapy with encouraging results in the treatment of hematological malignancies. At present, CD19 is the most ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced results from two analyses evaluating the effect of PD-L1 expression or prior treatment with immune checkpoint inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback